Trevigen/Cultrex®;干细胞合格的人卵黄连蛋白,PathClear®/3421-001-03/200μg

价格
¥5380.00
货号:3421-001-03
浏览量:127
品牌:Trevigen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Description

Cultrex®StemCellQualifiedHuman Vitronectin,Pathclear®ispurifiedfromhumanplasmaandisPathclear®certifiedtobefreeofcommonpathogens.Vitronectinisanextracellular,soluble,disulfide-linkeddimer,composedofa75kDaanda65kDapeptidechainwithatotalmolecularweightof140kDa.VitronectinisamajorplasmaglycoproteinthatpromotescellularadhesionandspreADIng.Italsoinhibitsthemembranedamagingeffectoftheterminalcytolyticcomplementpathwayandbindstoseveralserpinserineproteaseinhibitors.Vitronectin,alongwithcollagenIV,fibronectin,andlaminincansupportrobust,longtermproliferationofundifferentiatedhumanembryonicstemcells.Vitronectincanbeusedforcoatingtissueculturesurfacestopromotecelladhesion,proliferationanddifferentiation,orasanadditiveforserum-freemedia.Vitronectinispurifiedfromhumanplasmaandis0.2μmsterilefiltered.

Cultrex®StemCellQualifiedHumanVitronectin,Pathclear®isapurifiedplasmaextracellularmatrix proteinthathasbeendeveloped,producedandqualifiedtoprovideafunctionallydefinedandeffectivefeeder-freesurfacefortheattachmentandmaintenanceofembryonicstemcellsinapluripotentstate.

Qualitycontrolspecifications:

  • PathClear®–testednegativeforeighthumanpathogenicvirusesincludingHepatitisA,BandC,HIV1and2,Hantaan,Seoul,andSinNombrebyPCR.
  • Nobacterialorfungalgrowthdetectedafterincubationat37°Cfor14daysfollowingUSPsterilitytestingguidelines.
  • Endotoxinconcentration≤20EU/mlbyLimulusAmoebocyteLysate(LAL)assay.
  • Proteinconcentrationof1mg/ml.
  • NomycoplasmacontaminationdetectedbyPCR.
  • Providedin10mMSodiumPhosphate,pH7.7,8MUrea,5mMEDTA,500mMNaCl.
  • Purity ≥90%(SDS-PAGE).
  • BIOLOGicalactivitydeterminedforeachlot:
    • PromotestheattachmentofhumaniPSCs.
    • EffectivelymaintainshumaniPSCsinapluripotentstateinafeeder-freeculture.

SafetyStatement:

AlthoughCultrex®StemCellQualifiedHumanVitronectin,PathClear®hasbeentestedforthevirusesaboveitcontainshumansourcematerialandthereforeshouldbetreatedaspotentiallyinfectiousandhandledattheBiologicalSafetyLevel2tominimizeexposure.

 

Trevigen,Inc.是一家发展迅速的生物技术公司,致力于开发用于癌症研究,药物发现,遗传毒理学,再生医学和干细胞研究的产品和技术。我们提供试剂盒和试剂,用于研究DNA损伤和修复,细胞凋亡,氧化应激,癌细胞行为,3D培养和干细胞。该公司获得了美国国立卫生研究院(National Institutes of Health)多项SBIR资助。